Research News
- Organic NatureKnit Outperforms Purified Fibres in Gut Simulation Research highlights gentle fermentation, broader microbiome modulation, and higher SCFAs versus purified organic fibres at 48 hours. A newly published study in Frontiers in Nutrition is shining a spotlight on Organic NatureKnit®—an all-natural, organic, and patent-pending…
- Diabetes’ Next Profit Pool: The headline that changes the conversation In metabolic health, markets don’t pivot because of sentiment. They pivot when a new outcome starts to look plausible. That’s why insulin independence has become the most charged…
- Clinical Trial Shows Pycnogenol® May Relieve Lipedema Symptoms and Improve Quality of Life in Women Lipedema is one of those conditions that can quietly shape a woman’s daily life—pain, swelling, heaviness, tenderness, easy bruising—yet still be mislabelled as “just weight” or confused with other fluid and fat-distribution disorders. For…
- Menopause Relief Without Hormones: What the Evidence Says About Pycnogenol® Part 1 — Pycnogenol® & Menopause Series Why non-hormonal support matters now By 2025, more than one billion women will be in menopause or transitioning toward it, most between ages 45–55, with symptoms that…
- Pycnogenol® for Menopause: Evidence-Based, Hormone-Free Relief As per WHO, more than 1 billion women will experience menopause by 2025. Menopause transition is a life-changing phase that occurs between 45 and 55 years and can last from a few months up…
- Probi’s LP299V® + Iron: Signal a New Era for Women’s Health Supplements Iron deficiency remains one of the world’s most pressing nutritional challenges, especially for women of reproductive age. Nearly 30 percent of women aged 15-49 are affected. Traditional iron supplements often require high doses and…
- Nicotinamide Mononucleotide (NMN): The Promise and Challenges of an Emerging Anti-Aging Supplement Among the many molecules attracting attention, nicotinamide mononucleotide (NMN) stands out as a potential game-changer. Positioned as a precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential to cellular energy and repair, NMN is now marketed…
- Prevent Childhood Obesity The Retailer Playbook Childhood obesity remains a pressing concern in Canada, with combined overweight and obesity rates higher in adolescents than in younger children, and prevalence roughly double what it was in the late 1970s. Retailers are…
- FDA Authorisation for a First-of-Its-Kind Dual-Diagnosis Trial On July 7, 2025, Filament Health Corp. announced that the U.S. Food and Drug Administration has granted authorization to initiate a Phase 2 clinical trial of its botanical psilocybin candidate, PEX010, aimed at treating…
- William Shatner Amplifies Call for Tinnitus Research as Patient-Led “Tinnitus Quest” Debuts In a compelling two-minute video message, actor William Shatner has put his celebrity behind Tinnitus Quest, a newly established patient-led nonprofit dedicated to accelerating research into effective treatments for chronic tinnitus. The campaign’s launch marks…